Skip to main content
This page is marked noindex, nofollow and nosnippet: search engines are instructed not to index it, follow its links or reuse its content as a search-result excerpt. Citations and proposed references may contain errors or await review; this precaution limits reuse outside their evaluation context.

Citation test result: "FDA (2023). Communication on leucovorin use in cerebral folate deficiency"

Read-only replay of the candidates recorded in the corpus, using the current calculation engine. No external search or new saved test was created.

Checked on · Calculation version 2026-11-17.10-j20

The bibliographic score measures concordance of the evaluated fields. It is not a probability of certainty or an assessment of the scientific quality of the study.

Share this result

This page is public for sharing but is marked noindex/nosnippet for search engines.

Submitted cited reference

Raw citation
FDA (2023). Communication on leucovorin use in cerebral folate deficiency
Authors
FDA
Year
2023
Title
Communication on leucovorin use in cerebral folate deficiency
Journal
-
DOI
-

Best automated candidate

Candidate excluded
M1: Crossref, OpenAlex and PubMed Crossref Candidate rejected: very low title concordance and at most one matching element

Ionescu, Steluta; Nita, Manuela. (2023). RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS. Valahia University Law Study. doi:10.53373/vuls.2022.40.2.020

Divergent or partially matching elements: Authors, Title.

M1 is retained because its candidate score is higher than M2: 33.3/100 versus 7.4/100.

Candidate references (M1 and M2)

These are the candidates from each search channel before final metadata consolidation and validation.

Search channel Jaccard index Source Candidate reference
M1: Crossref, OpenAlex and PubMed 0.0% Crossref Ionescu, Steluta; Nita, Manuela. (2023). RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS. Valahia University Law Study. doi:10.53373/vuls.2022.40.2.020 https://doi.org/10.53373/vuls.2022.40.2.020

Low title correspondence: 0%

Divergent or partially matching elements: Authors, Title.

M2: Google Scholar via SerpApi 22.2% Google Scholar BN Rome; J Kim; JF Figueroa. (2026). Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders. Pediatrics. doi:10.1542/peds.2026-076794 https://doi.org/10.1542/peds.2026-076794

Low title correspondence: 22.2%

Divergent or partially matching elements: Authors, Title, Year. Year: 2023 cited; 2026 in the candidate record.

M1 is retained because its candidate score is higher than M2: 33.3/100 versus 7.4/100.

Bibliographic concordance score calculation

The score measures bibliographic concordance; it does not establish that a study exists or that its conclusions are valid.

Bibliographic concordance score : Provisional score 33.3/100 Final score : 0/100 · M1 · Title Jaccard : 0 %

Ionescu, Steluta; Nita, Manuela. (2023). RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS. Valahia University Law Study. doi:10.53373/vuls.2022.40.2.020

Candidate excluded

Divergent or partially matching elements: Authors, Title.

M1 is retained because its candidate score is higher than M2: 33.3/100 versus 7.4/100.

Candidate not validated: final score set to zero

Title Jaccard is 0%, below 20%, and only one other element is considered concordant: Year (100/100).

This combination indicates a high risk of an incorrect match. The provisional score is therefore reduced to zero. This does not establish that the cited publication does not exist.

For this rule, combined authors, journal and DOI count only at 100/100; the year also counts within one year. Other partial matches do not count as concordant elements. The candidate and all component scores remain visible for checking.

Evaluated fields: 3 out of 5.

Calculation details
Candidate comparison before metadata consolidation
Search channelCandidate score before consolidationTitle Jaccard
M133.3/1000.0 %
M27.4/10022.2 %
Authors
Cited
First author : FDA
Second author : Not provided
Found
First author : Ionescu, Steluta
Second author : Nita, Manuela
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Communication on leucovorin use in cerebral folate deficiency
Found
RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS
StatusScoreWeight
Non-concordant 0% 0.20
Year
Cited
2023
Found
2023
StatusScoreWeight
Concordant 100% 0.20
Journal
Cited
Not provided
Found
Valahia University Law Study
StatusScoreWeight
Not present (absent) — -
DOI
Cited
Not provided
Found
10.53373/vuls.2022.40.2.020
StatusScoreWeight
Not present (absent) — -

Provisional score before the rejection rule : (Authors 0.0x0.20 + Title 0.0x0.20 + Year 100.0x0.20) / evaluated weight 0.60 (Journal absent: 0.20 removed; DOI absent: 0.20 removed) = 33.3

Engine version : 2026-11-17.10-j20

Learn more about the score calculation

Title Jaccard index: 0.0%

Shared significant words / union: 0 / 14.

Missing title tokens: cerebral; communication; deficiency; folate; leucovorin; use

Extra title tokens: actuality; considerations; critical; debatable; law; right; some; synonymy

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.

All candidate results

RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS

Selected by automated ranking Low title correspondence: 0% M1: Crossref, OpenAlex and PubMed Crossref Candidate score before consolidation (M1: Crossref, OpenAlex and PubMed) : 33.3%

Ionescu, Steluta; Nita, Manuela. (2023). RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS. Valahia University Law Study. doi:10.53373/vuls.2022.40.2.020

Divergent or partially matching elements: Authors, Title.

Authors
Cited
First author : FDA
Second author : Not provided
Found
First author : Ionescu, Steluta
Second author : Nita, Manuela
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Communication on leucovorin use in cerebral folate deficiency
Found
RIGHT AND LAW - THE ACTUALITY OF A DEBATABLE SYNONYMY. SOME CRITICAL CONSIDERATIONS
StatusScoreWeight
Non-concordant 0% 0.20
Year
Cited
2023
Found
2023
StatusScoreWeight
Concordant 100% 0.20
Journal
Cited
Not provided
Found
Valahia University Law Study
StatusScoreWeight
Not present (absent) — -
DOI
Cited
Not provided
Found
10.53373/vuls.2022.40.2.020
StatusScoreWeight
Not present (absent) — -

(Authors 0.0x0.20 + Title 0.0x0.20 + Year 100.0x0.20) / evaluated weight 0.60 (Journal absent: 0.20 removed; DOI absent: 0.20 removed) = 33.3

Title Jaccard index: 0.0%

Shared significant words / union: 0 / 14.

Missing title tokens: cerebral; communication; deficiency; folate; leucovorin; use

Extra title tokens: actuality; considerations; critical; debatable; law; right; some; synonymy

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.

Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders

Low title correspondence: 22.2% M2: Google Scholar via SerpApi Google Scholar Candidate score before consolidation (M2: Google Scholar via SerpApi) : 7.4%

BN Rome; J Kim; JF Figueroa. (2026). Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders. Pediatrics. doi:10.1542/peds.2026-076794

Divergent or partially matching elements: Authors, Title, Year. Year: 2023 cited; 2026 in the candidate record.

Authors
Cited
First author : FDA
Second author : Not provided
Third author : Not provided
Found
First author : BN Rome
Second author : J Kim
Third author : JF Figueroa
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Communication on leucovorin use in cerebral folate deficiency
Found
Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders
StatusScoreWeight
Non-concordant 22.2% 0.20
Year
Cited
2023
Found
2026
StatusScoreWeight
Non-concordant 0% 0.20
Journal
Cited
Not provided
Found
Pediatrics
StatusScoreWeight
Not present (absent) — -
DOI
Cited
Not provided
Found
10.1542/peds.2026-076794
StatusScoreWeight
Not present (absent) — -

(Authors 0.0x0.20 + Title 22.2x0.20 + Year 0.0x0.20) / evaluated weight 0.60 (Journal absent: 0.20 removed; DOI absent: 0.20 removed) = 7.4

Title Jaccard index: 22.2%

Shared significant words / union: 2 / 9.

Shared title tokens: leucovorin; use

Missing title tokens: cerebral; communication; deficiency; folate

Extra title tokens: after; announcement; fda

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.